Stay updated on Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The latest version updates the record with changes to the study status and recruitment status, reflecting the trial's current state and related details.
    Difference
    0.1%
    Check dated 2025-11-03T01:30:08.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    29 days ago
    Change Detected
    Summary
    - Added a government funding and operating status notice and operating details for NIH Clinical Center. - Updated software version from v3.1.0 to v3.2.0.
    Difference
    11%
    Check dated 2025-10-05T12:07:33.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T09:27:28.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Updated study results page status to posted with expanded sections; removed the old “Results Submitted” label.
    Difference
    5%
    Check dated 2025-09-21T06:25:26.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Updated page revision to v3.0.2 (replacing v3.0.1); removed the 'Back to Top' element. Overall, a minor update with no substantive content changes.
    Difference
    0.7%
    Check dated 2025-09-14T00:00:26.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.7%
    Check dated 2025-09-06T17:58:39.000Z thumbnail image

Stay in the know with updates to Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.